Similarly, Zhao et al. investigated initial indications of a connection between β-receptor blockers targeting ADRB1 and glioblastoma progression by integrating eQTL colocalization with single-cell RNA-seq data (14). The gene discussed is ADRB1; the disease is glioblastoma.